Drug name - Xelpros

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9539262 SUN PHARM Ophthalmic composition comprising a prostaglandin Oct, 2028

(6 years from now)

US9629852 SUN PHARM Ophthalmic composition comprising a prostaglandin Sep, 2029

(6 years from now)

Drugs and Companies using LATANOPROST ingredient

Treatment: Reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension

Dosage: EMULSION;OPHTHALMIC

More Information on Dosage
Strength Dosage Availability
0.005% EMULSION;OPHTHALMIC Prescription

availability in other generic markets.

Click on the highlighted region to filter.